| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BMS-754807 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |